Hydroxyurea with dose escalation for primary stroke risk reduction in children with sickle cell anaemia in Tanzania (SPHERE): an open-label, phase 2 trial-Reference-Cited by-同舟云学术

Hydroxyurea with dose escalation for primary stroke risk reduction in children with sickle cell anaemia in Tanzania (SPHERE): an open-label, phase 2 trial

Published:2023-04 Issue:4 Volume:10 Page:e261-e271
ISSN:2352-3026
Container-title:The Lancet Haematology
language:en
Short-container-title:The Lancet Haematology

Author:

Ambrose Emmanuela E,Latham Teresa S,Songoro Primrose,Charles Mwesige,Lane Adam C,Stuber Susan E,Makubi Abel N,Ware Russell E,Smart Luke R

Publisher

Elsevier BV

Subject

Hematology

Reference29 articles.

1. Cerebrovascular accidents in sickle cell disease: rates and risk factors;Ohene-Frempong;Blood,1998

2. The use of transcranial ultrasonography to predict stroke in sickle cell disease;Adams;N Engl J Med,1992

3. Stroke and conversion to high risk in children screened with transcranial Doppler ultrasound during the STOP study;Adams;Blood,2004

4. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography;Adams;N Engl J Med,1998

5. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members;Yawn;JAMA,2014

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hydroxyurea in the sickle cell disease modern era;Expert Review of Clinical Pharmacology;2024-08-20

2. Current and emerging drug treatment strategies to tackle sickle cell anemia;Expert Opinion on Emerging Drugs;2024-07-22

3. Pharmacokinetic-Guided Hydroxyurea to Reduce Transfusions in Ugandan Children with Sickle Cell Anemia: Study Design of the Alternative Dosing And Prevention of Transfusions Trial;Acta Haematologica;2024-06-05

4. Hydroxyurea dose optimisation for children with sickle cell anaemia in sub-Saharan Africa (REACH): extended follow-up of a multicentre, open-label, phase 1/2 trial;The Lancet Haematology;2024-06

5. Bloodless management of significantly elevated transcranial Doppler velocity value in a Jehovah's witness child with sickle cell disease: A tertiary centre experience-A case report;Journal of the National Medical Association;2024-02